{
  "hypothesis": "h240",
  "title": "Calcium Blocker Cross-Category Repurposing",
  "outcome": "VALIDATED",
  "summary": {
    "high_confidence_precision": 53.8,
    "total_high_predictions": 13,
    "cross_category_findings": {
      "neurological": {
        "precision": 75.0,
        "count": 4,
        "status": "HIGH_PRIORITY"
      },
      "renal": {
        "precision": 33.3,
        "count": 3,
        "status": "VALIDATED"
      },
      "metabolic": {
        "precision": 25.0,
        "count": 8,
        "status": "LIMITED_EVIDENCE"
      },
      "ophthalmic": {
        "precision": 0.0,
        "count": 2,
        "status": "NOT_SUPPORTED"
      }
    }
  },
  "validated_repurposing_opportunities": [
    {
      "drug": "Verapamil",
      "disease": "Migraine with aura",
      "gt_hit": true,
      "evidence_level": "FDA-approved",
      "mechanism": "Reduces cortical spreading depression"
    },
    {
      "drug": "Verapamil/Diltiazem",
      "disease": "Epilepsy",
      "gt_hit": true,
      "evidence_level": "Supported",
      "mechanism": "CCBs modulate neuronal Ca2+ currents"
    },
    {
      "drug": "Amlodipine",
      "disease": "Cerebral infarction",
      "gt_hit": true,
      "evidence_level": "Supported (similar to nimodipine for SAH)",
      "mechanism": "Prevents cerebral vasospasm"
    },
    {
      "drug": "CCBs",
      "disease": "Diabetic nephropathy",
      "gt_hit": true,
      "evidence_level": "Established",
      "mechanism": "Renoprotective, reduce intraglomerular pressure"
    }
  ],
  "not_supported": [
    {
      "drug": "Amlodipine",
      "disease": "Glaucoma",
      "note": "Limited evidence"
    },
    {
      "drug": "Verapamil",
      "disease": "Hypercholesterolemia",
      "note": "No lipid effect"
    }
  ],
  "gabapentinoid_note": "Gabapentinoids (alpha2delta) have 0% precision for non-pain indications - should NOT be grouped with CCBs",
  "key_findings": [
    "CCBs show 75% precision for neurological repurposing (migraine, epilepsy)",
    "Verapamil \u2192 migraine is FDA-approved (model correctly predicts)",
    "CCBs \u2192 epilepsy aligns with T-type CCB anticonvulsant mechanisms",
    "CCBs \u2192 nephropathy is an established renoprotective indication",
    "Ophthalmic and lipid predictions NOT supported"
  ]
}